Cumberland Pharmaceuticals Ownership | Who Owns Cumberland Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Cumberland Pharmaceuticals Ownership Summary


Cumberland Pharmaceuticals is owned by 10.45% institutional investors, 41.64% insiders, and 47.91% retail investors. Millennium management is the largest institutional shareholder, holding 5.42% of CPIX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.01% of its assets in Cumberland Pharmaceuticals shares.

CPIX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCumberland Pharmaceuticals10.45%41.64%47.91%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.25%11.78%67.97%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management809.90K5.42%$3.43M
Ikarian capital555.93K3.72%$1.73M
Renaissance472.16K3.16%$1.88M
Vanguard group411.79K2.75%$1.64M
Dimensional fund advisors lp272.28K1.82%$1.08M
J. goldman & co lp208.14K1.39%$649.41K
Bridgeway capital management188.35K1.26%$587.67K
Boothbay fund management168.13K1.12%$524.57K
Blackrock110.56K0.78%$169.16K
Geode capital management107.27K0.72%$427.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital555.93K0.18%$1.73M
Heron bay capital management31.66K0.02%$98.79K
J. goldman & co lp208.14K0.02%$649.41K
Bridgeway capital management188.35K0.01%$587.67K
Boothbay fund management168.13K0.01%$524.57K
Renaissance472.16K0.00%$1.88M
Millennium management809.90K0.00%$3.43M
Xtx topco10.59K0.00%$33.04K
Acadian asset management44.29K0.00%$176.00K
Two sigma investments, lp37.59K0.00%$117.28K

Top Buyers

HolderShares% AssetsChange
Millennium management809.90K0.00%809.90K
Ubs group15.39K-14.56K
Geode capital management107.27K-5.65K
Two sigma investments, lp37.59K0.00%5.33K
Jones financial companies lllp600.00-600.00

Top Sellers

HolderShares% AssetsChange
Berkshire asset management llc/pa---153.81K
Adage capital partners gp---150.00K
Eam investors---71.78K
Walleye capital---70.42K
Renaissance472.16K0.00%-43.30K

New Positions

HolderShares% AssetsChangeValue
Millennium management809.90K0.00%809.90K$3.43M
Jones financial companies lllp600.00-600.00$1.85K

Sold Out

HolderChange
Citigroup-4.00
Jpmorgan chase-19.00
Advisor group-100.00
Wells fargo & company/mn-250.00
Farther finance advisors-345.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202515-54.55%1,562,989-54.11%102.01%5-44.44%4-69.23%
Sep 30, 202532-3,406,301-7.49%223.76%9-40.00%1220.00%
Jun 30, 202532-17.95%3,682,268-13.97%243.00%15-21.05%1011.11%
Mar 31, 20253-85.71%1,549,897-15.86%106.04%3-25.00%--100.00%
Dec 31, 202421-8.70%1,842,038-9.87%136.20%4-55.56%10150.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF280.82K2.01%-
Vanguard Total Stock Mkt Idx Inv274.81K1.84%-
Bridgeway Ultra-Small Company137.27K0.92%-
Vanguard Institutional Extnd Mkt Idx Tr86.94K0.58%-
IMC US Ultra Micro Cap79.25K0.53%-
DFA US Targeted Value I65.60K0.44%-
Fidelity Extended Market Index48.18K0.32%4.70K
DFA US Micro Cap I47.77K0.32%-
Pleiades Small Cap Equity A39.62K0.28%39.62K
Tete Inversiones Barcelona 2015 SICAV42.25K0.28%42.25K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 27, 2025Young Caroline-Buy$20.64
Aug 26, 2025Young Caroline-Buy$20.34
Aug 29, 2025Young Caroline-Buy$20.70
Aug 28, 2025Young Caroline-Buy$20.82
Aug 25, 2025Young Caroline-Buy$19.92

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q1--
2024 Q3--
2024 Q2--
2024 Q1--

CPIX Ownership FAQ


Who Owns Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals shareholders are primarily institutional investors at 10.45%, followed by 41.64% insiders and 47.91% retail investors. The average institutional ownership in Cumberland Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.25%, which Cumberland Pharmaceuticals falls below.

Who owns the most shares of Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals’s largest shareholders are Millennium management (809.9K shares, 5.42%), Ikarian capital (555.93K shares, 3.72%), and Renaissance (472.16K shares, 3.16%). Together, they hold 12.30% of Cumberland Pharmaceuticals’s total shares outstanding.

Does Blackrock own Cumberland Pharmaceuticals?

Yes, BlackRock owns 0.78% of Cumberland Pharmaceuticals, totaling 110.56K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 169.16K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Cumberland Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.18% of its assets in 555.93K Cumberland Pharmaceuticals shares, valued at 1.73M$.

Who is the top mutual fund holder of Cumberland Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cumberland Pharmaceuticals shares, with 2.01% of its total shares outstanding invested in 280.82K Cumberland Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools